Booth Andrew

Booth Andrew is listed in filings as Chief Financial Officer at AbCellera Biologics Inc.. This profile follows SEC Form 4 activity through Feb 27, 2026, including purchase activity. Recent filings connect the profile to AbCellera Biologics Inc. (ABCL). The current snapshot covers public activity from Jan 3, 2025 to Feb 27, 2026. Reported amounts are shown as $145.7K to $4.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.